Following the sale-and-leaseback purchase of Oxford Biomedica's Oxford headquarters in 2022, life sciences specialist Kadans Science Partner has announced a development deal for the property next door.
Private asset management company Kryalos has completed the acquisition of a light industrial property in Rome, through its Mars fund.
